Skip to main content

ACR21 Day 3 Recap- Polypharmacy, New Lupus Drugs, VEXAS, Safety Data

Nov 09, 2021 12:06 pm
ACR21 Day 3 Recap- Polypharmacy, New Lupus Drugs, VEXAS, Safety Data

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×